Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Hogendoorn
P C W
PC
Department of Pathology, University Medical Center, Leiden, The Netherlands.
Athanasou
N
N
Bielack
S
S
De Alava
E
E
Dei Tos
A P
AP
Ferrari
S
S
Gelderblom
H
H
Grimer
R
R
Hall
K Sundby
KS
Hassan
B
B
Hogendoorn
P C W
PC
Jurgens
H
H
Paulussen
M
M
Rozeman
L
L
Taminiau
A H M
AH
Whelan
J
J
Vanel
D
D
D000293:Adolescent; D000469:Alkaline Phosphatase / Q000097:blood; D015703:Antigens, CD / Q000097:blood; D001706:Biopsy; D017024:Chemotherapy, Adjuvant; D002648:Child; D003131:Combined Modality Therapy; D005060:Europe / Q000453:epidemiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008297:Male; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D012516:Osteosarcoma / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D010503:Periodic Acid-Schiff Reaction; D011379:Prognosis; D011878:Radiotherapy; D018570:Risk Assessment; D055502:Secondary Prevention; D016896:Treatment Outcome
D015703:Antigens, CD; D007770:L-Lactate Dehydrogenase; D000469:Alkaline Phosphatase